Physiomics (PYC)

 

PYC Share PerformanceMore

52 week high17.500 01/12/17
52 week low0.919 26/10/17
52 week change 5.365 (302.25%)
4 week volume37,104,548 21/12/17

Latest NewsMore

Result of AGM

RNS Number: 2619Z Physiomics PLC 13 December 2017 13 nd December 2017 Physiomics plc ("Physiomics") or ("the Company") AGM The Company held its Annual General Meeting at its offices in Oxford on 13 th December 2017 and is pleased to announce that all resolutions put to shareholders were passed. Enquiries: Physiomics plc Dr Jim Millen, CEO +44 (0)1865...

Director Deals - Physiomics PLC (PYC)

Dr Christophe Chassagnole, Executive Director, sold 600,000 shares in the company on the 12th December 2017 at a price of...

Director Deals - Physiomics PLC (PYC)

Dr James Millen, Chief Executive Officer, sold 240,000 shares in the company on the 12th December 2017 at a price of 8.30...

Director Dealing

RNS Number: 0902Z Physiomics PLC 12 December 2017 12 th December 2017 Physiomics plc ("Physiomics") or ("the Company") Director Dealing The Company announces that it received notice today that the following Directors sold the following number of ordinary shares in the Company at the following prices per share: Director Number of shares sold Sale pric...

Issue of Equity

RNS Number: 5908Y Physiomics PLC 06 December 2017 Physiomics plc ("Physiomics") or ("the Company") Issue of Equity Physiomics plc announces today that following the receipt of notice of exercise of employee options, 1,768,815 Ordinary Shares of 0.4p each in the Company (the "Options Shares") have now been issued to the following employees at the following...

Share Price Movement

RNS Number: 0132Y Physiomics PLC 30 November 2017 Physiomics plc ("Physiomics") or ("the Company") Share Price Movement Following the movement in the Physiomics share price today the Company would like to draw investors' attention to its RNS of the 28 th of November in which the Company announced the signing of a Master Services Agreement ("A...

Physiomics signs Merck partnership pact

Physiomics said its human virtual tumour project with Merck has been successfully completed and that it has entered into...

Clinical Project Completion and Services Agreement

RNS Number: 6248X Physiomics PLC 28 November 2017 Physiomics plc ("Physiomics") or ("the Company") Completion of VT Clinical Project with Merck and announcement of Master Services Agreement Physiomics plc (AIM: PYC) is pleased to announce that the human Virtual Tumour ("VT") project with Merck, a leading science and technology company, first...

Fundamental DataMore

EPS-0.78
Dividend yield0 %

Latest discussion posts More

  • News will come.....

    .....and when it does all the uncertainties will be in the past. I believe very soon the sp will turn around big time as pi's and traders get ready for some fireworks from ...
    10-Jan-2018
    dickie3times
  • 2nd Charge or Dead Cat Bounce?

    Only time will tell!!
    14-Dec-2017
    alltold9
  • week buy

    just been back from travels.i am glad i sold at 20.gla
    13-Dec-2017
    etadelete

Users' HoldingsMore

Users who hold Physiomics also hold..

Codes & Symbols

ISINGB00BDR6W943
SymbolsPYC, LSE:PYC, PYC.L, PYC:LN, LON:PYC, XLON:PYC

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account